Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Cardio-Oncology Scores
Interactive worksheet8 clinical inputsPatient data not stored

Mayo Clinic Cardiotoxicity Risk Score Calculator

Mayo Clinic Cardiotoxicity Risk Score: Explanation and Clinical Context The Mayo Clinic Cardiotoxicity Risk Score is a clinical tool designed to predict the risk of cardiotoxicity in cancer patients undergoing chemotherapy, particularly those treated with anthracyclines. This score integrates various patient-related risk factors, including age, gender, and the presence of cardiovascular comorbidities, to stratify pat

Interactive worksheet

Clinical inputs

0/8 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

Mayo Clinic Cardiotoxicity Risk Score: Explanation and Clinical Context The Mayo Clinic Cardiotoxicity Risk Score is a clinical tool designed to predict the risk of cardiotoxicity in cancer patients undergoing chemotherapy, particularly those treated with anthracyclines. This score integrates various patient-related risk factors, including age, gender, and the presence of cardiovascular comorbidities, to stratify patients into different risk categories. A higher risk score indicates a greater likelihood of developing cardiotoxicity, necessitating closer monitoring and potential preventive strategies.

Conversely, a lower score suggests a reduced risk, allowing for standard monitoring protocols. It is crucial to note that this score serves as a predictive tool and should be used in conjunction with clinical judgment and other diagnostic assessments to guide patient management.

Evidence & references2 primary sources mapped
  1. Source 1

    Jacobs JEJ, et al. "Mortality and Major Adverse Cardiac Events in Patients Receiving Anthracycline-Based Chemotherapy: Validation of the Mayo Clinic Cardiotoxicity Risk Score." Circulation: Cardiovascular Interventions,

  2. Source 2

    Open source

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

BNP Elevation Risk Tier (Cardiotoxicity Marker) Calculator

Cardio-Oncology Scores
Interactive worksheet

CHOP/Anthracycline Cumulative Dose Score Calculator

Cardio-Oncology Scores
Interactive worksheet

Radiation-Induced Heart Disease (RIHD) Dose Index Calculator

Cardio-Oncology Scores
Interactive worksheet

Mean Heart Dose (MHD) Risk Predictor

Cardio-Oncology Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.